Article Information
History
- July 15, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Mustafa Özçam1,
- Din L. Lin1,
- Chhedi L. Gupta1,2,#,
- Allison Li1,
- Lisa M. Wheatley3,
- Carolyn H. Baloh4,5,6,
- Srinath Sanda7,
- Stacie M. Jones8 and
- Susan V. Lynch1,*
- 1Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
- 2Benioff Center for Microbiome Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
- 3National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
- 4The Immune Tolerance Network, Boston, MA, USA
- 5Division of Allergy and Clinical Immunology, Brigham and Women’s Hospital, Boston, MA, USA
- 6Harvard Medical School, Boston, MA, USA
- 7The Immune Tolerance Network, San Francisco, CA, USA
- 8Division of Allergy and Immunology, Department of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children’s Hospital, Little Rock, AR, USA
- ↵*Corresponding author: susan.lynch{at}ucsf.edu
Posted July 15, 2024.
Enhanced Gut Microbiome Capacity for Amino Acid Metabolism is associated with Peanut Oral Immunotherapy Failure
